Related Experiment Video
Updated: Feb 11, 2026

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
Published on: July 6, 2013
Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors
Gray R Anderson1, Suzanne E Wardell1, Merve Cakir2
1Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, 27710, USA.
Abstract:
Altered mitochondrial dynamics can broadly impact tumor cell physiology. Using genetic and pharmacological profiling of cancer cell lines and human tumors, we here establish that perturbations to the mitochondrial dynamics network also result in specific therapeutic vulnerabilities. In particular, through distinct mechanisms, tumors with increased mitochondrial fragmentation or connectivity are hypersensitive to SMAC mimetics, a class of compounds that induce apoptosis through inhibition of IAPs and for which robust sensitivity biomarkers remain to be identified. Further, because driver oncogenes exert dominant control over mitochondrial dynamics, oncogene-targeted therapies can be used to sensitize tumors to SMAC mimetics via their effects on fission/fusion dynamics. Collectively, these data demonstrate that perturbations to the mitochondrial dynamics network induce targetable vulnerabilities across diverse human tumors and, more broadly, suggest that the altered structures, activities, and trafficking of cellular organelles may facilitate additional cancer therapeutic opportunities.
Insights
Altered mitochondrial dynamics create vulnerabilities in cancer cells. This study identifies specific mitochondrial structures that sensitize tumors to apoptosis-inducing SMAC mimetics, offering new therapeutic strategies.
Area of Science:
- Cell Biology
- Oncology
- Biochemistry
Background:
- Mitochondrial dynamics, including fission and fusion, are crucial for cancer cell function.
- Dysregulation of mitochondrial dynamics is observed in various cancers.
- Identifying therapeutic vulnerabilities linked to mitochondrial alterations is a key challenge in oncology.
Purpose of the Study:
- To investigate the link between mitochondrial dynamics and cancer therapeutic vulnerabilities.
- To identify specific mitochondrial network states that predict sensitivity to apoptosis-inducing drugs.
- To explore the potential of combining oncogene-targeted therapies with SMAC mimetics.
Main Methods:
- Genetic and pharmacological profiling of cancer cell lines and human tumors.
- Analysis of mitochondrial morphology (fragmentation and connectivity).
- Assessment of sensitivity to SMAC mimetics (Small Moleculeことをinduce Apoptosis).
Main Results:
- Tumors with increased mitochondrial fragmentation or connectivity exhibit hypersensitivity to SMAC mimetics.
- Distinct mechanisms underlie this hypersensitivity.
- Driver oncogenes influence mitochondrial dynamics, suggesting a role for oncogene-targeted therapies in sensitizing tumors.
Conclusions:
- Perturbations in the mitochondrial dynamics network create targetable vulnerabilities in diverse human tumors.
- Mitochondrial structure and dynamics can serve as biomarkers for SMAC mimetic therapy.
- Altered organelle structure and function represent promising avenues for novel cancer therapeutics.
Related Concept Videos
Animal Mitochondrial Genetics
Mitochondrial Protein Sorting
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Protein Transport into the Inner Mitochondrial Membrane
Transport of mitochondrial precursors across the TIM23 channel is driven by...
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Export of Mitochondrial and Chloroplast Genes

